Compare · BZUN vs YI
BZUN vs YI
Side-by-side comparison of Baozun Inc. (BZUN) and 111 Inc. (YI): market cap, price performance, sector, and recent activity on the wire.
Summary
- BZUN operates in Consumer Discretionary, while YI operates in Consumer Staples - the two are in different parts of the market.
- BZUN is the larger of the two at $209.8M, about 8.1x YI ($25.8M).
- BZUN has been more active in the news (5 items in the past 4 weeks vs 2 for YI).
- BZUN has more recent analyst coverage (15 ratings vs 0 for YI).
- Company
- Baozun Inc.
- 111 Inc.
- Price
- -
- -
- Market cap
- $209.8M
- $25.8M
- 1M return
- +4.02%
- -
- 1Y return
- +16.40%
- -
- Industry
- Catalog/Specialty Distribution
- Retail-Drug Stores and Proprietary Stores
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2015
- 2018
- News (4w)
- 5
- 2
- Recent ratings
- 15
- 0
Baozun Inc.
Baozun Inc. provides e-commerce solutions to brand partners in the People's Republic of China. The company's integrated end-to-end brand e-commerce capabilities encompass various aspects of the e-commerce value chain, including IT solutions, online store operations, digital marketing, customer services, warehousing, and fulfillment. It serves brand partners in various categories, including apparel and accessories; appliances; electronics; home and furnishings; food and health products; beauty and cosmetics; fast moving consumer goods, and mother and baby products; and insurance and automobiles. The company was formerly known as Baozun Cayman Inc. and changed its name to Baozun Inc. in March 2015. Baozun Inc. was founded in 2007 and is headquartered in Shanghai, the People's Republic of China.
111 Inc.
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Drug Mall, including pharmacies and wholesalers; and digital contract sales organization and data services. As of December 31, 2020, it operated 13 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Wuhan, Tianjin, and Kunshan. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. 111, Inc. has strategic partnerships with Bayer Healthcare Co. Ltd.; BeiGene, Ltd.; and Jianming Pharmaceutical Group. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.
Latest BZUN
- SEC Form 6-K filed by Baozun Inc.
- Baozun to Announce Third Quarter 2026 Unaudited Financial Results on November 24, 2026
- SEC Form 6-K filed by Baozun Inc.
- SEC Form 6-K filed by Baozun Inc.
- Chief Executive Officer Qiu Wenbin bought $39,900 worth of American Depositary Shares (11,400 units at $3.50) (SEC Form 4)
- SEC Form 6-K filed by Baozun Inc.
- Chief Executive Officer Qiu Wenbin bought $19,952 worth of American Depositary Shares (5,800 units at $3.44) (SEC Form 4)
- Chief Executive Officer Qiu Wenbin bought $40,166 worth of American Depositary Shares (11,800 units at $3.40) (SEC Form 4)
- SEC Form 6-K filed by Baozun Inc.
- SEC Form 6-K filed by Baozun Inc.
Latest YI
- SEC Form 6-K filed by 111 Inc.
- 111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
- Director Chen Yang Luke was granted 594,222 units of RSUs and sold $37,622 worth of RSUs (180,880 units at $0.21) (SEC Form 4) to cover taxes
- SEC Form 6-K filed by 111 Inc.
- 111, Inc. Announces Establishment of the Special Committee
- Director Chen Yang Luke sold $30,760 worth of RSUs (142,760 units at $0.22) and was granted 594,222 units of RSUs (SEC Form 4) (for tax liability)
- SEC Form 6-K filed by 111 Inc.
- SEC Form 6-K filed by 111 Inc.
- 111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company
- 111, Inc. Announces Second Quarter 2026 Unaudited Financial Results